<code id='379E77E138'></code><style id='379E77E138'></style>
    • <acronym id='379E77E138'></acronym>
      <center id='379E77E138'><center id='379E77E138'><tfoot id='379E77E138'></tfoot></center><abbr id='379E77E138'><dir id='379E77E138'><tfoot id='379E77E138'></tfoot><noframes id='379E77E138'>

    • <optgroup id='379E77E138'><strike id='379E77E138'><sup id='379E77E138'></sup></strike><code id='379E77E138'></code></optgroup>
        1. <b id='379E77E138'><label id='379E77E138'><select id='379E77E138'><dt id='379E77E138'><span id='379E77E138'></span></dt></select></label></b><u id='379E77E138'></u>
          <i id='379E77E138'><strike id='379E77E138'><tt id='379E77E138'><pre id='379E77E138'></pre></tt></strike></i>

          Home / knowledge / comprehensive

          comprehensive


          comprehensive

          author:entertainment    Page View:98658
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In